2019
Differentiating spontaneous echo contrast, sludge, and thrombus in the left atrial appendage: Can ultrasound enhancing agents help?
Posada‐Martinez E, Trejo‐Paredes C, Ortiz‐Leon X, Ivey‐Miranda J, Lin BA, McNamara RL, Arias‐Godinez J, Lombo B, Sugeng L. Differentiating spontaneous echo contrast, sludge, and thrombus in the left atrial appendage: Can ultrasound enhancing agents help? Echocardiography 2019, 36: 1413-1417. PMID: 31260135, DOI: 10.1111/echo.14405.Peer-Reviewed Original Research
2015
Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.
Lombo B, Alkhalil I, Golden MP, Fotjadhi I, Ravi S, Virata M, Lievano M, Diez J, Ghantous A, Donohue T. Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy. Connecticut Medicine 2015, 79: 277-81. PMID: 26245015.Peer-Reviewed Original ResearchConceptsCombination antiretroviral therapyInternational Diabetes FederationMetabolic syndromeProtease inhibitor darunavirAntiretroviral therapyNational Cholesterol Education Program Adult Treatment Panel III criteriaAdult Treatment Panel III criteriaDuration of cARTHighly Active Antiretroviral TherapyActive antiretroviral therapyATP III criteriaMetabolic syndrome prevalenceStandard of careUrban community hospitalLogistic regression analysisHIV patientsStudy patientsHIV diseaseIDF criteriaDiabetes FederationHIV infectionSyndrome prevalenceCommunity hospitalHigh prevalenceObservational study